2014 ASCO AM Public - Monday - ASCO


Powered by SmugMug Log In
New Evidence on the Role of Surgery and PET Scans after Primary Chemoradiotherapy

New Evidence on the Role of Surgery and PET Scans after Primary Chemoradiotherapy

Chicago, IL - 2015 ASCO Annual Meeting - Hisham Mohamed Mehanna, MD, PhD presents PET-NECK: A multi-centre, randomized, phase III, controlled trial (RCT) comparing PETCT guided active surveillance with planned neck dissection (ND) for locally advanced (N2/N3) nodal metastases (LANM) in patients with head and neck squamous cell cancer (HNSCC) treated with primary radical chemoradiotherapy (CRT) during New Evidence on the Role of Surgery and PET Scans after Primary Chemoradiotherapy at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Monday, June 1, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org